ADC	apparent diffusion coefficients
BT	brachytherapy
CBCT	cone beam computed tomography
CI	confidence interval
CRT	chemo-radiotherapy
CT	computed tomography
CTV	clinical target volume
DCE MRI	dynamic contrast-enhanced MRI
DW-MRI	diffusion-weighted MRI
DFS	disease free survival
DRR	digitally reconstructed radiograph
EBRT	external beam radiotherapy
EMBRACE	European study on MRI-guided brachytherapy in locally advanced cervical cancer
EQD2	biologically equivalent dose in 2 Gy fractions
FDG	fluorodeoxyglucose
FIGO	International Federation of Gynaecology and Obstetrics
GEC-	The Groupe Européen de Curiethérapie and the European society for ESTRO radiotherapy & oncology
GOG	Gynecologic Oncology Group
GTV	gross tumor volume
HDR	high dose rate
HR CTV	high risk clinical target volume
ICRU	International Comission on Radiation Units and Measurements
IGABT	image-guided adaptive brachytherapy
IGRT	image-guided radiotherapy
IMRT	intensity modulated radiation therapy
IR CTV	intermediate risk clinical target volume
ITV	internal target volume
LACC	locally advanced cervical cancer
LC	local control
LDR	low dose rate
LINAC	linear accelerator
LN	lymph node
MLC	multileaf collimator
MRI	magnetic resonance imaging
OARs	organs at risk
OS	overall survival
OTT	overall treatment time
PA	paraaortic
PDR	pulsed dose rate
PET	positron emission tomography
PTV	planning target volume
RTOG	Radiation Therapy Oncology Group
SIB	simultaneous integrated boost
SWOG	Southwest Oncology Group
T	Tesla